T311—An Anti-Tyrosinase Monoclonal Antibody for the Detection of Melanocytic Lesions in Paraffin Embedded Tissues
- 31 December 2000
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 196 (4) , 235-242
- https://doi.org/10.1016/s0344-0338(00)80072-2
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Melan-A, A New Melanocytic Differentiation MarkerAdvances in Anatomic Pathology, 1999
- Expression of Melan-A (MART1) in Benign Melanocytic Nevi and Primary Cutaneous Malignant MelanomaThe American Journal of Surgical Pathology, 1998
- Comparison of immunohistochemical staining of the novel antibody melan‐A with S100 protein and HMB‐45 in malignant melanoma and melanoma variantsHistopathology, 1998
- Immunoreactivity for A103, an Antibody to Melan-A (Mart-1), in Adrenocortical and Other Steroid TumorsThe American Journal of Surgical Pathology, 1998
- Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineageBritish Journal of Cancer, 1997
- Cancer Tumor antigensCurrent Opinion in Immunology, 1997
- Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.Proceedings of the National Academy of Sciences, 1995
- Tyrosinase Gene Expression in Human TissuesPigment Cell Research, 1993
- The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1993
- Illegitimate transcription: transcription of any gene in any cell type.Proceedings of the National Academy of Sciences, 1989